Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel analgesics described in a recent University of Tennessee patent

Oct. 28, 2008

Noscira to initiate phase II NP-12 study in Alzheimer's disease

Oct. 28, 2008

Schering-Plough's asenapine meets primary endpoint in schizophrenia relapse prevention trial

Oct. 28, 2008

New compounds for neurological disorders reported in recent patents

Oct. 28, 2008

CHMP adopts negative opinion on Cymbalta for the treatment of fibromyalgia

Oct. 27, 2008

Further clinical trials suspended for GRC-6211 in osteoarthritis pain

Oct. 27, 2008

EMEA issues positive opinion for Lunivia MAA in Europe

Oct. 27, 2008

Johnson & Johnson submits NDA to FDA for carisbamate

Oct. 27, 2008

GSK and Affiris sign exclusive license and option agreement for therapeutic AD vaccines

Oct. 27, 2008

Toxicity of antispastic agent azumolene evaluated in vivo

Oct. 27, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...